134 related articles for article (PubMed ID: 17624450)
1. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease.
Zuo G; Li Z; Chen L; Xu X
Antiviral Res; 2007 Oct; 76(1):86-92. PubMed ID: 17624450
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity-guided fractionation of an antidiarrheal Chinese herb Rhodiola kirilowii (Regel) Maxim reveals (-)-epicatechin-3-gallate and (-)-epigallocatechin-3-gallate as inhibitors of cystic fibrosis transmembrane conductance regulator.
Chen L; Yu B; Zhang Y; Gao X; Zhu L; Ma T; Yang H
PLoS One; 2015; 10(3):e0119122. PubMed ID: 25747701
[TBL] [Abstract][Full Text] [Related]
3. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
[TBL] [Abstract][Full Text] [Related]
4. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease.
Duan D; Li Z; Luo H; Zhang W; Chen L; Xu X
Bioorg Med Chem Lett; 2004 Dec; 14(24):6041-4. PubMed ID: 15546725
[TBL] [Abstract][Full Text] [Related]
5. In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds.
Zuo GY; Li ZQ; Chen LR; Xu XJ
Antivir Chem Chemother; 2005; 16(6):393-8. PubMed ID: 16329286
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq.
Wang SY; Tseng CP; Tsai KC; Lin CF; Wen CY; Tsay HS; Sakamoto N; Tseng CH; Cheng JC
Biochem Biophys Res Commun; 2009 Jul; 385(2):230-5. PubMed ID: 19450556
[TBL] [Abstract][Full Text] [Related]
7. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
[TBL] [Abstract][Full Text] [Related]
8. A review of HCV protease inhibitors.
Chen KX; Njoroge FG
Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
Liu R; Abid K; Pichardo J; Pazienza V; Ingravallo P; Kong R; Agrawal S; Bogen S; Saksena A; Cheng KC; Prongay A; Njoroge FG; Baroudy BM; Negro F
J Antimicrob Chemother; 2007 Jan; 59(1):51-8. PubMed ID: 17151003
[TBL] [Abstract][Full Text] [Related]
10. Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.
Chung V; Carroll AR; Gray NM; Parry NR; Thommes PA; Viner KC; D'Souza EA
Antimicrob Agents Chemother; 2005 Apr; 49(4):1381-90. PubMed ID: 15793116
[TBL] [Abstract][Full Text] [Related]
11. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
[TBL] [Abstract][Full Text] [Related]
12. In vivo assay for hepatitis C viral serine protease activity using a secreted protein.
Cho YG; Yang SH; Sung YC
J Virol Methods; 1998 May; 72(1):109-15. PubMed ID: 9672138
[TBL] [Abstract][Full Text] [Related]
13. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
[TBL] [Abstract][Full Text] [Related]
15. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease.
Yang L; Lin J; Zhou B; Liu Y; Zhu B
Nat Prod Res; 2017 Feb; 31(4):487-491. PubMed ID: 27295355
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
17. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
18. Potent aza-peptide derived inhibitors of HCV NS3 protease.
Venkatraman S; Wu W; Shih NY; George Njoroge F
Bioorg Med Chem Lett; 2009 Aug; 19(16):4760-3. PubMed ID: 19596195
[TBL] [Abstract][Full Text] [Related]
19. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease.
Hegde VR; Pu H; Patel M; Das PR; Butkiewicz N; Arreaza G; Gullo VP; Chan TM
Bioorg Med Chem Lett; 2003 Sep; 13(17):2925-8. PubMed ID: 14611859
[TBL] [Abstract][Full Text] [Related]
20. Establishment and application of high throughput screening model for hepatitis C virus NS3-4A protease inhibitors in vitro.
Jian-rui L; Yan-bin W; Shu-yi S; Hong-shan C; Jian-dong J; Zong-gen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):98-101. PubMed ID: 21375947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
